Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
Scientific research: Milan calls Europe
di Luca Carra
Milan may be considered one of the main centers of Italian research, at least in its international and cooperative dimension, as it is demonstrated by the data regarding the Seventh Framework Programme (FP7) that Scienceonthenet have analyzed(1). From such data, the great research centers of Milan clearly stands out, especially in the fields of biomedicine, energy and information technology, but there are also hundreds of small enterprises that collaborate with partners from abroad, in a “Europe of knowledge” that is still to be fully discovered.
